These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15865599)

  • 1. Profound hypocalcaemia after zoledronic acid treatment.
    Nguyen HV; Ingram KB; Beilin J
    Med J Aust; 2005 May; 182(9):494-5. PubMed ID: 15865599
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma.
    Singh D; Khaira NS; Sekhon JS
    Ann Oncol; 2004 Dec; 15(12):1848. PubMed ID: 15550594
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.
    Jones SG; Dolan G; Lengyel K; Myers B
    Br J Haematol; 2002 Nov; 119(2):576-7. PubMed ID: 12406106
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.
    Noriega Aldave AP; Jaiswal S
    J Med Case Rep; 2014 Oct; 8():353. PubMed ID: 25342294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A
    J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
    Henley D; Kaye J; Walsh J; Cull G
    Intern Med J; 2005 Dec; 35(12):726-8. PubMed ID: 16313549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid.
    Chennuru S; Koduri J; Baumann MA
    Intern Med J; 2008 Aug; 38(8):635-7. PubMed ID: 18284458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrolyte abnormalities with zoledronic acid therapy.
    Sorscher SM
    Cancer J; 2002; 8(4):348; author reply 348-9. PubMed ID: 12184414
    [No Abstract]   [Full Text] [Related]  

  • 9. Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration.
    Navarro M; López R; Alaña M; Ocaña A; Leno R; Sánchez F; Fonseca E; Cruz JJ
    J Palliat Med; 2007 Dec; 10(6):1226-7. PubMed ID: 18095793
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors contributing to the development of hypocalcemia after zoledronic acid administration in patients with bone metastases of solid tumor.
    Hanamura M; Iwamoto T; Soga N; Sugimura Y; Okuda M
    Biol Pharm Bull; 2010; 33(4):721-4. PubMed ID: 20410614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?
    Ho JW; Sundar S
    Clin Genitourin Cancer; 2012 Mar; 10(1):50-3. PubMed ID: 22245101
    [No Abstract]   [Full Text] [Related]  

  • 12. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
    Kaur U; Chakrabarti SS; Gambhir IS
    Curr Drug Saf; 2016; 11(3):267-9. PubMed ID: 27113952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid.
    Perman MJ; Lucky AW; Heubi JE; Azizkhan RG
    Arch Dermatol; 2009 Jan; 145(1):95-6. PubMed ID: 19153360
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid.
    Corsello SM; Paragliola RM; Locantore P; Ingraudo F; Ricciato MP; Rota CA; Senes P; Pontecorvi A
    Hormones (Athens); 2010; 9(4):338-42. PubMed ID: 21112866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Avascular osteonecrosis of the jaws induced by diphosphonates].
    Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
    Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe hypocalcaemia after being given intravenous bisphosphonate.
    Peter R; Mishra V; Fraser WD
    BMJ; 2004 Feb; 328(7435):335-6. PubMed ID: 14764499
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
    Patel K; Brahmbhatt V; Ramu V
    Tenn Med; 2005 Feb; 98(2):83-5, 89. PubMed ID: 15779196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia.
    Cure E; Yuce S; Cure MC
    Minerva Endocrinol; 2013 Jun; 38(2):217-8. PubMed ID: 23732377
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
    Tanvetyanon T; Choudhury AM
    Ann Pharmacother; 2004 Mar; 38(3):418-21. PubMed ID: 14970365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
    Koike K; Morishige S; Fukami K; Taguchi K; Yakushiji K; Okamura T; Okuda S
    Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):179-81. PubMed ID: 21387650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.